SPARC

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE232I01014
NSEID: SPARC
BSEID: 532872
View on NSE | View on BSE

INR

132.10

-2.85 (-2.11%)

BSENSE

Feb 13

BSE+NSE Vol: 4.48 lacs

{
  "main_header": {
    "sid": 739743,
    "name": "SPARC",
    "stock_name": "SPARC",
    "full_name": "Sun Pharma Advanced Research Company Ltd",
    "name_url": "stocks-analysis/sparc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "132.10",
    "chg": -2.85,
    "chgp": "-2.11%",
    "dir": -1,
    "prev_price": "134.95",
    "mcapval": "4,290.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532872,
    "symbol": "SPARC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE232I01014",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "4.48 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sparc-739743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharma Advanced Research Company Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharma-advanced-research-company-ltd-is-rated-strong-sell-3834900",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_mojoScore_3834900.png",
        "date": "2026-02-12 10:10:26",
        "description": "Sun Pharma Advanced Research Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2024, but the analysis below reflects the stock’s current position as of 12 February 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      },
      {
        "title": "Are Sun Pharma Advanced Research Company Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sun-pharma-advanced-research-company-ltd-latest-results-good-or-bad-3829052",
        "imagepath": "",
        "date": "2026-02-09 19:15:58",
        "description": "Sun Pharma Advanced Research Company Ltd's latest financial results for Q3 FY26 indicate significant operational challenges. The company reported a net loss of ₹80.42 crores, reflecting a year-on-year decline of 1.14%. Revenue for the quarter was ₹8.45 crores, which represents a substantial year-on-year contraction of 43.33%. Although there was a marginal sequential improvement in sales of 7.51% from the previous quarter, this is overshadowed by the overall revenue decline.\n\nThe operating margin stood at -670.30%, indicating a severe disconnect between the company's expenses and its revenue-generating capacity. Employee costs alone reached ₹31.18 crores, significantly exceeding total sales for the quarter. This unsustainable cost structure has resulted in operating losses deepening to ₹56.64 crores before interest and depreciation.\n\nThe balance sheet position has also deteriorated, with shareholder funds tu..."
      },
      {
        "title": "Sun Pharma Advanced Research Q3 FY26: Mounting Losses Signal Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/sun-pharma-advanced-research-q3-fy26-mounting-losses-signal-deepening-crisis-3828983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_quaterlyResult_3828983.png",
        "date": "2026-02-09 16:34:00",
        "description": "Sun Pharma Advanced Research Company Ltd. (SPARC), the clinical-stage biopharmaceutical subsidiary of Sun Pharma, reported a net loss of ₹80.42 crores in Q3 FY26, marking yet another quarter of significant cash burn for the struggling research firm. Whilst the loss showed marginal improvement from the previous quarter's ₹75.85 crores deficit, the company's revenues continue to deteriorate sharply, plunging 43.33% year-on-year to just ₹8.45 crores. With a market capitalisation of ₹4,587 crores and negative book value, SPARC's stock trades at ₹138.30, down 32.29% from its 52-week high, reflecting mounting investor concerns about the company's viability."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Gains 10.10%: Mixed Technical Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-gains-1010-mixed-technical-signals-shape-weekly-momentum-3826380",
        "imagepath": "",
        "date": "2026-02-07 15:09:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Mixed technical signals amid price momentum shift</p>\n                    <p><strong>3 Feb:</strong> Intraday high surge to Rs.148.10 with strong gap up</p>\n                    <p><strong>4 Feb:</strong> Continued mixed technical signals with price volatility</p>\n                    <p><strong>5 Feb:</strong> Minor pullback amid bearish momentum</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.139.05, slightly down from prior days</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.126.30</div></div>\n                    <d..."
      },
      {
        "title": "When is the next results date for Sun Pharma Advanced Research Company Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sun-pharma-advanced-research-company-ltd-3821213",
        "imagepath": "",
        "date": "2026-02-04 23:17:00",
        "description": "The next results date for Sun Pharma Advanced Research Company Ltd is scheduled for 09 February 2026...."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-shows-mixed-technical-signals-amid-price-momentum-shift-3819712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_technicaldot_3819712.png",
        "date": "2026-02-04 08:04:33",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. While some weekly and monthly indicators suggest mild bullishness, others remain bearish or neutral, signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Hits Intraday High with 10.77% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-hits-intraday-high-with-1077-surge-3818411",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_priceRelatedfactors_3818411.png",
        "date": "2026-02-03 11:06:23",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 148.1, marking an 11.1% increase from its previous close. The stock outperformed both its sector and the broader market, reflecting significant trading momentum amid a mixed market backdrop."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_gapup_3817698.png",
        "date": "2026-02-03 09:42:53",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) commenced trading on 3 Feb 2026 with a significant gap up, opening 7.99% higher than its previous close. This robust start reflects positive market sentiment within the Pharmaceuticals & Biotechnology sector, as the stock outperformed both its sector peers and the broader Sensex index during the day."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-faces-bearish-momentum-amid-technical-downturn-3817192",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunPharmaAdvanc_technicaldot_3817192.png",
        "date": "2026-02-03 08:02:52",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest intraday volatility, the stock’s technical parameters suggest increasing downside risks, reflecting broader challenges in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 172,
    "sid": "739743",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharma-advanced-research-company-739743"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Feb-2026",
      "details": "Newspaper Advertisement for Publication of Financials",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for For Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "09-Feb-2026",
      "details": "Outcome of the Board Meeting for Approval of Unaudited Financial Results for the Quarter and Nine Months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "09-Feb-2026",
      "details": "Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharma Advanced Research Company Ltd has announced <strong>5:116</strong> rights issue, ex-date: 16 Mar 16",
          "dt": "2016-03-16",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Sun Pharma Advanced Research Company Ltd is Rated Strong Sell

2026-02-12 10:10:26

Sun Pharma Advanced Research Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2024, but the analysis below reflects the stock’s current position as of 12 February 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Read full news article

Are Sun Pharma Advanced Research Company Ltd latest results good or bad?

2026-02-09 19:15:58

Sun Pharma Advanced Research Company Ltd's latest financial results for Q3 FY26 indicate significant operational challenges. The company reported a net loss of ₹80.42 crores, reflecting a year-on-year decline of 1.14%. Revenue for the quarter was ₹8.45 crores, which represents a substantial year-on-year contraction of 43.33%. Although there was a marginal sequential improvement in sales of 7.51% from the previous quarter, this is overshadowed by the overall revenue decline. The operating margin stood at -670.30%, indicating a severe disconnect between the company's expenses and its revenue-generating capacity. Employee costs alone reached ₹31.18 crores, significantly exceeding total sales for the quarter. This unsustainable cost structure has resulted in operating losses deepening to ₹56.64 crores before interest and depreciation. The balance sheet position has also deteriorated, with shareholder funds tu...

Read full news article

Sun Pharma Advanced Research Q3 FY26: Mounting Losses Signal Deepening Crisis

2026-02-09 16:34:00

Sun Pharma Advanced Research Company Ltd. (SPARC), the clinical-stage biopharmaceutical subsidiary of Sun Pharma, reported a net loss of ₹80.42 crores in Q3 FY26, marking yet another quarter of significant cash burn for the struggling research firm. Whilst the loss showed marginal improvement from the previous quarter's ₹75.85 crores deficit, the company's revenues continue to deteriorate sharply, plunging 43.33% year-on-year to just ₹8.45 crores. With a market capitalisation of ₹4,587 crores and negative book value, SPARC's stock trades at ₹138.30, down 32.29% from its 52-week high, reflecting mounting investor concerns about the company's viability.

Read full news article

Sun Pharma Advanced Research Company Ltd Gains 10.10%: Mixed Technical Signals Shape Weekly Momentum

2026-02-07 15:09:37

Key Events This Week

2 Feb: Mixed technical signals amid price momentum shift

3 Feb: Intraday high surge to Rs.148.10 with strong gap up

4 Feb: Continued mixed technical signals with price volatility

5 Feb: Minor pullback amid bearish momentum

6 Feb: Week closes at Rs.139.05, slightly down from prior days

Week Open

Rs.126.30

Read full news article

When is the next results date for Sun Pharma Advanced Research Company Ltd?

2026-02-04 23:17:00

The next results date for Sun Pharma Advanced Research Company Ltd is scheduled for 09 February 2026....

Read full news article

Sun Pharma Advanced Research Company Ltd Shows Mixed Technical Signals Amid Price Momentum Shift

2026-02-04 08:04:33

Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. While some weekly and monthly indicators suggest mild bullishness, others remain bearish or neutral, signalling a cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Sun Pharma Advanced Research Company Ltd Hits Intraday High with 10.77% Surge

2026-02-03 11:06:23

Sun Pharma Advanced Research Company Ltd (SPARC) demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 148.1, marking an 11.1% increase from its previous close. The stock outperformed both its sector and the broader market, reflecting significant trading momentum amid a mixed market backdrop.

Read full news article

Sun Pharma Advanced Research Company Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 09:42:53

Sun Pharma Advanced Research Company Ltd (SPARC) commenced trading on 3 Feb 2026 with a significant gap up, opening 7.99% higher than its previous close. This robust start reflects positive market sentiment within the Pharmaceuticals & Biotechnology sector, as the stock outperformed both its sector peers and the broader Sensex index during the day.

Read full news article

Sun Pharma Advanced Research Company Ltd Faces Bearish Momentum Amid Technical Downturn

2026-02-03 08:02:52

Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest intraday volatility, the stock’s technical parameters suggest increasing downside risks, reflecting broader challenges in the Pharmaceuticals & Biotechnology sector.